Approval · Notice of Compliance 14477 · 2013
JAYDESS: Notice of Compliance 14477
Issued June 19, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14477
- Date
- June 19, 2013
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Progestogen
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| JAYDESS | 02408295 | Cancelled Post Market |
Medicinal ingredients
- LEVONORGESTREL 13.5 MG per UNIT